One of the emerging trends is the development of drugs targeting new receptors. For example, some drugs are acting on the fibroblast growth factor - 21 receptor, which can increase energy expenditure and have shown good potential in preclinical studies. If these drugs can be successfully developed, they may provide new treatment options for obese patients.

Another trend is the improvement of drug dosage forms. Pharmaceutical companies are working on developing long-acting drugs and oral drugs to improve patient compliance. For example, the oral versions of semaglutide and tirzepatide are being developed, which will bring more convenience to patients compared with the current injection forms.

In addition, the combination of different drugs or the combination of drugs and other treatment methods is also an important direction. For example, the combination of GLP-1 agonists and amylin analogues has shown a synergistic effect in promoting weight loss in some studies. The combination of drugs and lifestyle interventions such as diet and exercise can also achieve better treatment results.

Although there are many emerging trends in the research and development of obesity treatment drugs, there are still many challenges. The R & D of new drugs requires a lot of time and resources, and it is necessary to overcome many technical difficulties and safety issues. However, with the continuous progress of science and technology, it is believed that more effective and safe obesity treatment drugs will emerge in the future.